C5 and paroxysmal nocturnal hemoglobinuria: However, the actual number of diagnosed patients with PNH with high disease activity and who require treatment is lower: in the Netherlands, there are approximately 140 patients diagnosed with PNH, 80–90 of whom require treatment with a complement C5 inhibitor [6, 7].